SpringWorks Therapeutics Stock
SpringWorks is a medicines company.
Sign up today and learn more about SpringWorks Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About SpringWorks Therapeutics Stock
They are a different type of therapeutic development company purpose-built for the 21st century. SpringWorks Therapeutics is on a mission to connect scientists, biopharmaceutical partners, patient groups, funders and philanthropists to deliver promising, transformative science to underserved patients. Their name symbolizes their mission-driven approach to therapeutic development—they’re springing into action to deliver treatments to people who are in urgent need.
Funding History
| September 2017 | $103M |
|---|
Management
President and Founder
Lara S. Sullivan
Executive Chairman
Daniel S. Lynch
Chief Financial Officer and Chief Business Officer
Saqib Islam
Press
Business Wire (press release) - Mar, 5 2018
SpringWorks Therapeutics to Present at Cowen and Company's 38Baltimore Business Journal - Feb, 2 2018
These Maryland companies received the most venture capital in 2017MedCity News - Sep, 29 2017
Pfizer spin-off SpringWorks embraces shelved therapiesHIT Consultant - Sep, 27 2017
Pfizer Spin Off Lands $103M to Develop New Drugs for Undeserved Patient PopulationsEquityZen Recognized As:
